Research roundup

Debbie Rigby 06/05/2025

Debbie Rigby takes a look at the latest in research news Mirtazapine for chronic insomnia in older adults: a randomised double-blind placebo-controlled trial-the MIRAGE study Mirtazapine promotes sleep by blocking serotonin and histaminergic receptors and is often used off-label to treat chronic insomnia. This randomised, double-blind, placebo-controlled trial shows that mirtazapine significantly reduces insomnia severity and improves

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Research roundup

Previous CWH founders expand property empire

Next Sigma reports positive results

MENU

ajp.com.au

Previous CWH founders expand property empire

Next Sigma reports positive results

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.